metabolic vulnerabilities in cml & the impact of tkis on glucose anaplerosis
Published 1 year ago • 42 plays • Length 4:25Download video MP4
Download video MP3
Similar videos
-
2:09
targeting mitochondrial metabolism in cml
-
3:18
granulocytes & t-cells as biomarkers for relapse in cml following discontinuation of tkis
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:06
assessing metabolic tumor volume as a prognostic marker before car-t therapy for dlbcl
-
1:17
ponatinib versus ascimininib in the third-line treatment of cml
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:06
chanelle thornton - chronic myeloid leukaemia (cml) - spot leukaemia
-
9:25
mgus diagnosis: a step-by-step approach
-
9:33
detecting cml (chronic myeloid leukemia) w/ digital pcr | #labchat
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
3:16
aml metabolism may be the key to successful treatment
-
4:02
testing for bcr::abl kinase mutations in cml and how they impact tki resistance
-
2:27
ascembl: asciminib versus bosutinib in third-line treatment of cp-cml
-
0:41
isct in bringing together the scientific community
-
1:11
the standardization of flow cytometry
-
1:03
insights into the cartitude-6 trial: rationale and design
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
2:09
clonal lymphopoiesis and how this plays a role in predisposition to waldenström's macroglobulinemia
-
0:48
evolving treatment goals in cml
-
4:27
cml management in resource limited countries
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml